We are live on ! Find out more
BCM

Bratton Capital Management Portfolio holdings

AUM $40.7M
1-Year Est. Return 43.1%
This Fund
S&P 500
This Quarter Est. Return
+10.08%
1 Year Est. Return
+43.1%
3 Year Est. Return
+264.04%
5 Year Est. Return
-20.19%
10 Year Est. Return
–
AUM
$61.5M
AUM Growth
-$10.4M
Cap. Flow
-$16.1M
Cap. Flow %
-26.08%
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
–
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
DNLI icon
Denali Therapeutics
DNLI
+$16.1M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AQST icon
1
Aquestive Therapeutics
AQST
$452M
$61.5M 100%
11,503,294
– –
DNLI icon
2
Denali Therapeutics
DNLI
$3.79B
– –
-448,035
Closed -$16.1M

Similar funds

SCM
Stadium Capital Management New Canaan, Connecticut $40.6M AUM 5.83% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
CPCM
Cornerstone Partners Capital Management Charlottesville, Virginia $40.3M AUM 33.69% 1-Year Est. Return
CIC
Cincinnati Indemnity Company Fairfield, Ohio $40.3M AUM 2.56% 1-Year Est. Return
LSA
Liberty Street Advisors New York $41.4M AUM 34.47% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
CF
Crosspoint Financial Tustin, California $39.8M AUM 14.13% 1-Year Est. Return
ICP
Indus Capital Partners New York $39.7M AUM 53.95% 1-Year Est. Return

Bratton Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Bratton Capital Management held 2 positions worth $61.5M, down 14% from $71.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Bratton Capital Management withdrew a net $16.1M in Q4 2020, closing 1 position. Its most notable exit was Denali Therapeutics, an estimated $16.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Bratton Capital Management fully exited Denali Therapeutics in Q4 2020, selling an estimated $16.1M.
  • Bratton Capital Management's ten largest holdings make up 100% of its $61.5M portfolio in Q4 2020.
  • Bratton Capital Management opened 0 new positions and closed 1 in Q4 2020.
  • Bratton Capital Management's portfolio value fell 14% quarter-over-quarter to $61.5M.

Based on Bratton Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.